- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Biocon Limited — Updates, 11-11-2025: Press Release
11-11-2025 | 08:47 pm
11-11-2025 | 08:47 pm
Biocon Q2FY26 operating revenue rose 20% to Rs 4,296 Cr, EBITDA up 29% to Rs 928 Cr, and PBT soared 153% to Rs 183 Cr. Strong Biosimilars and Generics growth drove results. Debt settlement strengthens the balance sheet. Company opened its first US manufacturing facility.
No comments yet. Be the first to comment!